U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H23N3O2
Molecular Weight 385.4583
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIFEPRUNOX

SMILES

O=C1NC2=CC=CC(N3CCN(CC4=CC=CC(=C4)C5=CC=CC=C5)CC3)=C2O1

InChI

InChIKey=CYGODHVAJQTCBG-UHFFFAOYSA-N
InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)

HIDE SMILES / InChI
Molecular Formula C24H23N3O2
Molecular Weight 385.4583
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
123738
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:38:33 UTC 2023
Edited
by admin
on Fri Dec 15 16:38:33 UTC 2023
Record UNII
AP69E83Z79
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BIFEPRUNOX
INN   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
Bifeprunox [WHO-DD]
Common Name English
bifeprunox [INN]
Common Name English
7-[4-(Biphenyl-3-ylmethyl)piperazin-1-yl]benzoxazol-2(3H)-one
Systematic Name English
BIFEPRUNOX [MI]
Common Name English
BIFEPRUNOX [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29710
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
Code System Code Type Description
FDA UNII
AP69E83Z79
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
NCI_THESAURUS
C65262
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
INN
8266
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
SMS_ID
100000089783
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
ChEMBL
CHEMBL218166
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
EVMPD
SUB20312
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
MESH
C509981
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
WIKIPEDIA
BIFEPRUNOX
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
MERCK INDEX
m2484
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY Merck Index
DRUG BANK
DB04888
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
CAS
350992-10-8
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
PUBCHEM
208951
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
EPA CompTox
DTXSID80188592
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
USAN
RR-138
Created by admin on Fri Dec 15 16:38:33 UTC 2023 , Edited by admin on Fri Dec 15 16:38:33 UTC 2023
PRIMARY
Related Record Type Details
D(2) DOPAMINE RECEPTOR
TARGET->PARTIAL AGONIST
Structure of BIFEPRUNOX MESYLATE
SALT/SOLVATE -> PARENT
5-HYDROXYTRYPTAMINE RECEPTOR 1A
TARGET -> AGONIST
Related Record Type Details
Structure of BIFEPRUNOX
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966